Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate

Fig. 3

Boxplots for all subgroups of DVH target volume dose values D98% and D95% for PTV and GTV/CTV (*GTV for all cases except prostate; CTV in case of prostate) for the predicted (pr.) and re-optimized (re.) dose distributions. Dose normalized to the ideally achieved PTV encompassing dose (see sub-section “Comparison of DVH parameters and statistical analysis”)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us